Skip to content

Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score

Phase 1 of Clinical Trial of Risk Factor, Prognosis, Imaging and Standard Management of Transient Ischemic Attack.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00553241
Enrollment
1
Registered
2007-11-05
Start date
2007-06-30
Completion date
2009-01-31
Last updated
2009-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Attack, Transient

Keywords

TIA, prognosis, evaluation, management

Brief summary

The purpose of this study is to determine whether the ABCD2 score can be used in patients with transient ischemic attack, admitted to Beijing anzhen hospital, to evaluate the prognosis, risk factor of those patients.

Detailed description

The feasibility of risk stratification of patients with acute transient ischemic attack admitted to Beijing anzhen hospital by the ABCD2 score system is yet to be determined. The aim of this paper was to evaluate and validate the short-term prognosis of TIA patients in Peking area using this new score system.

Interventions

None listed

Sponsors

Beijing Anzhen Hospital
CollaboratorOTHER
Capital Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Every patient admitted to Beijing anzhen hospital with transient ischemic attack will be enrolled in this study, from 06/2007 to 12/2008. duration of the symptom not larger than 1 hour. * Magnetic resonance imaging negative on DWI(no fresh infarction). * Old infarction or not the criminal infarction.

Exclusion criteria

* Patients with hemorrhage stroke were excluded.

Design outcomes

Primary

MeasureTime frame
end points are defined as follow: transient ischemic attack, stroke, angina, myocardial infraction, peripheral vascular disease, intracerebral hemorrhage and other vascular death.two year

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026